Assignee
GTC BIOTHERAPEUTICS INC
US·8 granted patents·19 pending applications·147 citations·filing 1998–2012
Top patents by PatentIndex Score
27 records- 0190US7531632B2Clarification of transgenic milk using depth filtrationGTC BIOTHERAPEUTICS INC·Filed 2006·Granted May 12, 2009·29 cites·28 claims
- 0290US7354594B2Merozoite surface protein 1 lacking glycosylation sitesGTC BIOTHERAPEUTICS INC·Filed 2005·Granted Apr 8, 2008·6 cites·27 claims
- 0388US7101971B2Erythropoietin analog-human serum albumin fusionGTC BIOTHERAPEUTICS INC·Filed 2002·Granted Sep 5, 2006·21 cites·20 claims
- 0486US7928064B2Transgenically produced antithrombin IIIGTC BIOTHERAPEUTICS INC·Filed 2005·Granted Apr 19, 2011·21 cites·5 claims
- 0584US7501553B2Non-human transgenic mammal comprising a modified MSP-1 nucleic acidGTC BIOTHERAPEUTICS INC·Filed 2002·Granted Mar 10, 2009·8 cites·43 claims
- 0684US7019193B2Treatments using transgenic goat produced antithrombin IIIGTC BIOTHERAPEUTICS INC·Filed 2002·Granted Mar 28, 2006·44 cites·10 claims
- 0777US7550263B2Method for the production of fusion proteins in transgenic mammal milkGTC BIOTHERAPEUTICS INC·Filed 2004·Granted Jun 23, 2009·13 cites·23 claims
- 0860US2011229460A1anti-cd137 antibody as an agent in the treatment of inflammatory conditionsGTC BIOTHERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 0956US2009246194A1ERYTHROPOIETIN ANALOG-IgG FUSION PROTEINSGTC BIOTHERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 1055US2010056757A1Clarification of transgenic milk using depth filtrationGTC BIOTHERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1155US2008118501A1Antibodies with enhanced antibody-dependent cellular cytotoxicity activity, methods of their production and useGTC BIOTHERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1254US2006179493A1Transgenically produced non-secreted proteinsGTC BIOTHERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1354US2010021612A1Method for the production of fusion proteins in transgenic mammal milkGTC BIOTHERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1454US2005160483A1Transgenically produced decorinGTC BIOTHERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 1553US2006191025A1Method for the rapid selection of homozygous primary cell lines for the production of transgenic animals by somatic cell nuclear transferGTC BIOTHERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1651US2008004212A1Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombinGTC BIOTHERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1751US2006179500A1Methods and vectors for improving nucleic acid expressionGTC BIOTHERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 1850US2013149301A1Anti-cd137 antibody as an agent in the treatment of inflammatory conditionsGTC BIOTHERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 1949US2006178309A1Method for the crystallization of human serum albuminGTC BIOTHERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2048US2006191029A1Method and system for fusion and activation following nuclear transfer in reconstructed embryosGTC BIOTHERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2146US2006123500A1Methods of prescreening cells for nuclear transfer proceduresGTC BIOTHERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 2245US2011082083A1Formulations of liquid stable antithrombinGTC BIOTHERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 2345US2006174359A1Method for selecting cell lines to be used for nuclear transfer in mammalian speciesGTC BIOTHERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2445US2005260672A1Methods of tangential flow filtration and an apparatus thereforeGTC BIOTHERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 2545US2007037192A1Method of purifying recombinant human antithrombin to enhance the viral and prion safety profileGTC BIOTHERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2643US7632980B1Modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systemsGTC BIOTHERAPEUTICS INC·Filed 1998·Granted Dec 15, 2009·5 cites·8 claims
- 2738US2005197496A1Methods of protein fractionation using high performance tangential flow filtrationGTC BIOTHERAPEUTICS INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GTC BIOTHERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →